- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Bone health and treatments
- Cancer, Lipids, and Metabolism
- Legal and Policy Issues
- European and International Law Studies
- Free Radicals and Antioxidants
- Medical and Biological Sciences
- Advanced Glycation End Products research
- Radiopharmaceutical Chemistry and Applications
- Angiogenesis and VEGF in Cancer
- Tannin, Tannase and Anticancer Activities
- Genomics, phytochemicals, and oxidative stress
- Cell Adhesion Molecules Research
- Endometrial and Cervical Cancer Treatments
- Flavonoids in Medical Research
- 3D Modeling in Geospatial Applications
- Advanced Breast Cancer Therapies
- Ovarian cancer diagnosis and treatment
- Cervical Cancer and HPV Research
- Glutathione Transferases and Polymorphisms
Financial University
2024
Ministry of Health of the Russian Federation
2020-2021
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation
2019
Рак шейки матки: проблемы профилактики и скрининга в Российской ФедерацииЛ.А
Results of ELISA investigation the pretreatment sPD-1 and sPD-L1 content in blood serum 133 bone neoplasms patients aged 6-70 years 57 practically healthy control persons 12-70 are described. In 14 were a benign character, 16 - borderline giant-cell tumor was diagnosed, 103 malignant lesions including 39 osteosarcomas 42 chondrosarcomas revealed. The receptor concentrations did not differ between primary patients, while level statistically significantly increased (p<0.0000001). By means...
The article considers the problem of role constituent entities Russian Federation in implementing mechanism for division jurisdictions and powers between its entities. author provides a general description this differentiation analyzes evolution. Now, takes place mainly through federal laws. However, adoption these laws is within jurisdiction carried out special procedure — legislative process. Therefore, evaluates their legislation. identifies main problems formulates few promising...
The data of a comparative enzyme-linked immunosorbent assay the content soluble form immunity checkpoint VISTA in blood serum 30 healthy donors (control group), 79 patients with primary malignant (osteosarcoma - 30, chondrosarcoma 31, chordoma 14) and 14 borderline (giant cell tumor) bone neoplasms are presented. In general group bones, median sVISTA is statistically significant lower than control (p = 0.040). tumors over 18 years age, there was decrease age levels. There were no differences...
<h3>Introduction/Background</h3> At present, there are numerous confirmed data on multitarget effect of indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) against tumors different origin. The aim was to study the effectiveness combined therapy for patients with ovarian cancer (OC) when I3C EGCG included in its scheme. <h3>Methodology</h3> 284 an ascitic form advanced serous OC. All them underwent treatment: polychemotherapy (TP, TC, DC) cytoreductive surgery. same time, treatment...